Literature DB >> 1763795

DNA sequences for the specific detection of Cryptosporidium parvum by the polymerase chain reaction.

M A Laxer1, B K Timblin, R J Patel.   

Abstract

The objective of this project was to construct specific and sensitive molecular probes and amplification primers for Cryptosporidium parvum that could be used in diagnosis, retrospective tissue studies, and in epidemiologic surveys. Whole genomic DNA was extracted from oocysts of C. parvum purified from human and bovine feces. A genomic library was constructed in plasmid pUC18 and propagated in Escherichia coli DH5 alpha. Transformants were screened by colony hybridization and autoradiography. The 2.3-kilobase segment in plasmid pHC1, a clone specific for C. parvum, was sequenced by the Sanger method. Computer analysis gave a G+C content of 35%. A 400-base region (bases 470-870) was selected as an amplification target because it contained a unique restriction endonuclease site that could serve as a useful marker. Primers of 26 nucleotides each were synthesized. Sensitive and specific amplification of the target sequence was demonstrated both by ethidium bromide staining of agarose and acrylamide gels, and by hybridization with chemiluminescence-labeled synthetic oligonucleotide probes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763795     DOI: 10.4269/ajtmh.1991.45.688

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  40 in total

1.  Immunomagnetic capture PCR to detect viable Cryptosporidium parvum oocysts from environmental samples.

Authors:  M Q Deng; D O Cliver; T W Mariam
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

2.  Prevalence of and associated risk factors for shedding Cryptosporidium parvum oocysts and Giardia cysts within feral pig populations in California.

Authors:  E R Atwill; R A Sweitzer; M G Pereira; I A Gardner; D Van Vuren; W M Boyce
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

3.  Comparison of diagnostic techniques for the detection of Cryptosporidium oocysts in animal samples.

Authors:  Marzieh Ezzaty Mirhashemi; Annetta Zintl; Tim Grant; Frances E Lucy; Grace Mulcahy; Theo De Waal
Journal:  Exp Parasitol       Date:  2015-02-03       Impact factor: 2.011

4.  Evaluation of two DNA template preparation methods for post-immunomagnetic separation detection of Cryptosporidium parvum in foods and beverages by PCR.

Authors:  Christian D Frazar; Palmer A Orlandi
Journal:  Appl Environ Microbiol       Date:  2007-09-21       Impact factor: 4.792

Review 5.  A hundred-year retrospective on cryptosporidiosis.

Authors:  Saul Tzipori; Giovanni Widmer
Journal:  Trends Parasitol       Date:  2008-03-07

6.  Detection of cryptosporidium and identification to the species level by nested PCR and restriction fragment length polymorphism.

Authors:  Stephane Coupe; Claudine Sarfati; Samia Hamane; Francis Derouin
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 7.  DNA probes and PCR for diagnosis of parasitic infections.

Authors:  J B Weiss
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Detection and genotyping of oocysts of Cryptosporidium parvum by real-time PCR and melting curve analysis.

Authors:  Sultan Tanriverdi; Atila Tanyeli; Fikri Başlamişli; Fatih Köksal; Yurdanur Kilinç; Xiaochuan Feng; Glenda Batzer; Saul Tzipori; Giovanni Widmer
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Assessment of microscopic and molecular tools for the diagnosis and follow-up of cryptosporidiosis in patients at risk.

Authors:  Y Le Govic; K Guyot; G Certad; A Deschildre; R Novo; C Mary; B Sendid; E Viscogliosi; L Favennec; E Dei-Cas; E Fréalle; E Dutoit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-26       Impact factor: 3.267

Review 10.  Cryptosporidiosis: an emerging, highly infectious threat.

Authors:  R L Guerrant
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.